AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31320277 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus biofeedback
Number of subjects: 300
Study 28641863 — intervention group
Group type: COMPARATOR
Intervention: Passive (survival jacket)
Number of subjects: 20
Study 28641863 — intervention group
Group type: COMPARATOR
Intervention: Active (7 min rewarm-up after 8 min rest)
Number of subjects: 20
Study 28641863 — intervention group
Group type: COMPARATOR
Intervention: Combined (7 min rewarm-up after 8 min wearing survival jacket)
Number of subjects: 20
Study 27350654 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol dependent participants
Number of subjects: 0
Study 27350654 — intervention group
Group type: COMPARATOR
Intervention: Non-alcohol dependent participants
Number of subjects: 0
Study 23775701 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteo‐cise program (n=81)
Number of subjects: 162
Study 23775701 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=81)
Number of subjects: 162
Study 22828718 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART) initiation
Number of subjects: 0
Study 22828718 — intervention group
Group type: EXPERIMENTAL
Intervention: CD4+ T-cell counts >500 cells/mm³
Number of subjects: 0
Study 22828718 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-1 RNA >400 copies/mL
Number of subjects: 0
Study 22828718 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease-inhibitor (PI)-based regimen
Number of subjects: 0
Study 20084587 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepping Stones Triple P
Number of subjects: 0
Study 18050577 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite (Group 1)
Number of subjects: 50
Study 18050577 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite plus 17% EDTAC (Group 2)
Number of subjects: 50
Study 18050577 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA gel combined with 5.25% sodium hypochlorite (Group 3)
Number of subjects: 50
Study 18050577 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gel (Group 4)
Number of subjects: 50
Study 18050577 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite combined with Glyde File Prep gel (Group 5)
Number of subjects: 50
Study 16085507 — intervention group
Group type: EXPERIMENTAL
Intervention: General portion snus
Number of subjects: 0
Study 16085507 — intervention group
Group type: EXPERIMENTAL
Intervention: Catch Licorice portion snus
Number of subjects: 0
Study 16085507 — intervention group
Group type: EXPERIMENTAL
Intervention: Catch Mini portion snus
Number of subjects: 0
Study 16085507 — intervention group
Group type: EXPERIMENTAL
Intervention: Catch Dry Mini portion snus
Number of subjects: 0
Study 16085507 — intervention group
Group type: COMPARATOR
Intervention: 2-mg Nicorette gum
Number of subjects: 0
Study 11966664 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous M6G 2 mg
Number of subjects: 10
Study 11966664 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous M6G 2 mg
Number of subjects: 10
Study 11966664 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized M6G 4 mg
Number of subjects: 10
Study 11966664 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral M6G 20 mg
Number of subjects: 10
Study 11966664 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous and subcutaneous M6G
Number of subjects: 10
Study 10189144 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 1054
Study 10189144 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 1054
Study 10189144 — intervention group
Group type: COMPARATOR
Intervention: Control (no calcium antagonist)
Number of subjects: 1054
Study 7478029 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin/nitroglycerin infused in the same site
Number of subjects: 98
Study 7478029 — intervention group
Group type: COMPARATOR
Intervention: Heparin/nitroglycerin infused in separate sites
Number of subjects: 98
Study 1695225 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict glycemic control
Number of subjects: 79
Study 1695225 — intervention group
Group type: COMPARATOR
Intervention: Customary glycemic control
Number of subjects: 79
Study 1695225 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic pregnancies
Number of subjects: 79
Study 1695225 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic subjects with pregestational hypertension or microvascular disease
Number of subjects: 79
Study 1695225 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic subjects with pregnancy-induced hypertension
Number of subjects: 79
Study 29982371 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional appliance treatment for 12 months
Number of subjects: 20
Study 29982371 — intervention group
Group type: COMPARATOR
Intervention: Control group (age- and gender-matched children without immediate orthodontic treatment need)
Number of subjects: 20
Study 27605591 — intervention group
Group type: EXPERIMENTAL
Intervention: Accu-Chek® FlexLink Plus (FL Plus)
Number of subjects: 80
Study 27605591 — intervention group
Group type: COMPARATOR
Intervention: Accu-Chek® FlexLink infusion set (FL)
Number of subjects: 80
Study 25322972 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Therapy (MT)
Number of subjects: 31
Study 25322972 — intervention group
Group type: COMPARATOR
Intervention: Music Medicine (MM)
Number of subjects: 31
Study 23438045 — intervention group
Group type: EXPERIMENTAL
Intervention: Miconazole (MIC)
Number of subjects: 30
Study 23438045 — intervention group
Group type: EXPERIMENTAL
Intervention: Ricinus communis (RC)
Number of subjects: 30
Study 23438045 — intervention group
Group type: COMPARATOR
Intervention: Nystatin (NYS)
Number of subjects: 30
Study 21550483 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin plus clavulanic acid (3 g per day for 8-15 days)
Number of subjects: 239
Study 21550483 — intervention group
Group type: COMPARATOR
Intervention: Emergency appendicectomy
Number of subjects: 239
Study 21550483 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin plus clavulanic acid
Number of subjects: 239
Study 20028307 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast bandaid removal
Number of subjects: 65
Study 20028307 — intervention group
Group type: COMPARATOR
Intervention: Slow bandaid removal
Number of subjects: 65
Study 17061635 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS 25
Number of subjects: 40
Study 17061635 — intervention group
Group type: COMPARATOR
Intervention: BIS 40
Number of subjects: 40
Study 15163472 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II (30.5 g fiber, 4.11 g soluble fiber)
Number of subjects: 53
Study 15163472 — intervention group
Group type: COMPARATOR
Intervention: Group I (10.4 g fiber, 1.97 g soluble fiber)
Number of subjects: 53
Study 11334767 — intervention group
Group type: EXPERIMENTAL
Intervention: CS-866
Number of subjects: 2145
Study 11334767 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2145
Study 15321225 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural diamorphine 2.5 mg in 10 ml normal saline following spinal anaesthesia
Number of subjects: 58
Study 15321225 — intervention group
Group type: COMPARATOR
Intervention: Epidural diamorphine 2.5 mg in 10 ml normal saline following conventional epidural anaesthesia
Number of subjects: 58
Study 8165073 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrofurantoin prophylaxis (once-daily dose)
Number of subjects: 56
Study 8165073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 2832173 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg day-1 for 5 days
Number of subjects: 12
Study 2832173 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide added to enalapril therapy
Number of subjects: 12
Study 2832173 — intervention group
Group type: COMPARATOR
Intervention: Frusemide alone (before enalapril)
Number of subjects: 12
Study 29800122 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dietary intervention (n=19,541)
Number of subjects: 48835
Study 29800122 — intervention group
Group type: COMPARATOR
Intervention: Usual-diet comparison group (n=29,294)
Number of subjects: 48835
Study 27942799 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-intensity walking (LW): sitting plus 3 min bouts of light-intensity walking at 3.2 km/h every 30 min
Number of subjects: 24
Study 27942799 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple resistance activities (SRA): sitting plus 3 min bouts of simple resistance activities every 30 min
Number of subjects: 24
Study 27942799 — intervention group
Group type: COMPARATOR
Intervention: Prolonged sitting (SIT)
Number of subjects: 24
Study 26156323 — intervention group
Group type: EXPERIMENTAL
Intervention: Community mobilization protocol
Number of subjects: 85182
Study 22948783 — intervention group
Group type: EXPERIMENTAL
Intervention: Eggs on toast
Number of subjects: 30
Study 22948783 — intervention group
Group type: COMPARATOR
Intervention: Cereal (cornflakes) with milk and toast
Number of subjects: 30
Study 22948783 — intervention group
Group type: COMPARATOR
Intervention: Croissant and orange juice
Number of subjects: 30
Study 20860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute secondhand smoke exposure (1 hour, mean fine particulate matter < 2.5 μm level = 315 ± 116 μg/m(3))
Number of subjects: 25
Study 17851680 — intervention group
Group type: COMPARATOR
Intervention: Aqueous solution (AS)
Number of subjects: 17
Study 17851680 — intervention group
Group type: COMPARATOR
Intervention: Protein-rich food bar (PP)
Number of subjects: 17
Study 17851680 — intervention group
Group type: COMPARATOR
Intervention: Beta-glucan-rich food bar (BG)
Number of subjects: 17
Study 17851680 — intervention group
Group type: EXPERIMENTAL
Intervention: All forms of creatine ingestion
Number of subjects: 17
Study 17851680 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine ingestion
Number of subjects: 17
Study 16455626 — intervention group
Group type: COMPARATOR
Intervention: Presymptomatic HD subjects (n = 24)
Number of subjects: 71
Study 16455626 — intervention group
Group type: COMPARATOR
Intervention: Clinically unaffected subjects at risk for HD and symptomatic patients
Number of subjects: 71
Study 16455626 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal follow-up of HD subjects (n = 10)
Number of subjects: 71
Study 14514236 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental prophylaxis plus placebo capsule
Number of subjects: 366
Study 14514236 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) plus placebo capsule
Number of subjects: 366
Study 14514236 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) plus metronidazole capsule (250 mg t.i.d. for one week)
Number of subjects: 366
Study 14514236 — intervention group
Group type: COMPARATOR
Intervention: Untreated reference group (723 pregnant women with periodontitis)
Number of subjects: 366
Study 10740958 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasonable woman legal standard
Number of subjects: 200
Study 10740958 — intervention group
Group type: COMPARATOR
Intervention: Reasonable person legal standard
Number of subjects: 200
Study 8864710 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir (ACV) 4 g/day for at least a week
Number of subjects: 105
Study 8864710 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 105
Study 1497054 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol 400 mg/day for 4 months (n = 22)
Number of subjects: 42
Study 1497054 — intervention group
Group type: COMPARATOR
Intervention: Hysterectomy (n = 20)
Number of subjects: 42
Study 6342168 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous labetalol (0.25 mg/kg)
Number of subjects: 0
Study 6342168 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous labetalol (0.5 mg/kg)
Number of subjects: 0
Study 6342168 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous practolol (0.4 mg/kg)
Number of subjects: 0
Study 6342168 — intervention group
Group type: COMPARATOR
Intervention: Saline (1 ml)
Number of subjects: 0
Study 31874872 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient feedback intervention using the PREOS‐PC survey
Number of subjects: 1248
Study 31874872 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 1248
Study 30243898 — intervention group
Group type: EXPERIMENTAL
Intervention: Kettlebell training (KT)
Number of subjects: 33
Study 30243898 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 33
Study 27227930 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunonutrition (immune-enhancing feed)
Number of subjects: 264
Study 27227930 — intervention group
Group type: COMPARATOR
Intervention: Control supplement (hypercaloric hypernitrogenous supplement)
Number of subjects: 264
Study 27227930 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunonutrition
Number of subjects: 264
Study 27227930 — intervention group
Group type: COMPARATOR
Intervention: Control supplement
Number of subjects: 264
Study 24863086 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 73
Study 24863086 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 21793707 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential Newborn Care training
Number of subjects: 25096
Study 21793707 — intervention group
Group type: COMPARATOR
Intervention: Neonatal resuscitation training
Number of subjects: 25096
Study 20158293 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent intervention with vouchers based on breath carbon monoxide levels and urinary cotinine levels, with earnings starting at $9.00 and increasing by $1.50 for each negative sample, maximum possible of $362.50.
Number of subjects: 40
Study 20158293 — intervention group
Group type: COMPARATOR
Intervention: Noncontingent intervention with vouchers independent of smoking status.
Number of subjects: 40
Study 19018906 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic information intervention
Number of subjects: 0
Study 19018906 — intervention group
Group type: COMPARATOR
Intervention: Regular medical intervention
Number of subjects: 0
Study 16969618 — intervention group
Group type: EXPERIMENTAL
Intervention: Seprafilm under the midline incision and around the stoma (Group I)
Number of subjects: 191
Study 16969618 — intervention group
Group type: EXPERIMENTAL
Intervention: Only under the midline incision (Group II)
Number of subjects: 191
Study 16969618 — intervention group
Group type: COMPARATOR
Intervention: Not to receive Seprafilm (Group III)
Number of subjects: 191
Study 12680331 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin aspartic-acid injection (monotherapy, once-daily intravenous dosing)
Number of subjects: 19
Study 10232636 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinol (60 mg as retinyl palmitate)
Number of subjects: 212
Study 10232636 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene (7.6 mg daily)
Number of subjects: 212
Study 10232636 — intervention group
Group type: COMPARATOR
Intervention: Placebo (daily)
Number of subjects: 212
Study 8912406 — intervention group
Group type: EXPERIMENTAL
Intervention: d-fenfluramine (FEN) 15 mg, PO
Number of subjects: 0
Study 8912406 — intervention group
Group type: EXPERIMENTAL
Intervention: d-fenfluramine (FEN) 30 mg, PO
Number of subjects: 0
Study 8912406 — intervention group
Group type: EXPERIMENTAL
Intervention: d-fenfluramine (FEN)
Number of subjects: 0
Study 1886022 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate rinse
Number of subjects: 139
Study 1886022 — intervention group
Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 139
Study 6340917 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulant
Number of subjects: 119
Study 6340917 — intervention group
Group type: COMPARATOR
Intervention: Bed rest for 24 hours
Number of subjects: 119
Study 29543617 — intervention group
Group type: EXPERIMENTAL
Intervention: IDHF‐001
Number of subjects: 91
Study 29543617 — intervention group
Group type: COMPARATOR
Intervention: Restylane SubQ
Number of subjects: 91
Study 28398947 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 g·kg of body mass of ammonium chloride (NH4Cl, acidosis)
Number of subjects: 11
Study 28398947 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 g·kg of sodium bicarbonate (NaHCO3, alkalosis)
Number of subjects: 11
Study 28398947 — intervention group
Group type: COMPARATOR
Intervention: 0.15 g·kg of CaCO3 (placebo)
Number of subjects: 11
Study 25449195 — intervention group
Group type: EXPERIMENTAL
Intervention: FES-assisted active cycling
Number of subjects: 40
Study 25449195 — intervention group
Group type: COMPARATOR
Intervention: Active cycling without FES (Control)
Number of subjects: 40
Study 25449195 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (FES and Control)
Number of subjects: 40
Study 23791495 — intervention group
Group type: EXPERIMENTAL
Intervention: 5mg of morphine sulfate intramuscularly
Number of subjects: 53
Study 23791495 — intervention group
Group type: COMPARATOR
Intervention: 5mg of haloperidol intramuscularly
Number of subjects: 53
Study 21205123 — intervention group
Group type: EXPERIMENTAL
Intervention: IDet + SITA + MET
Number of subjects: 0
Study 21205123 — intervention group
Group type: COMPARATOR
Intervention: SITA + MET ± SU
Number of subjects: 0
Study 19083486 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical nutrition therapy (MNT) emphasizing dietary folate intake, performed 5 times during the 12 weeks of the experiment.
Number of subjects: 40
Study 19083486 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical nutrition therapy (MNT) emphasizing dietary folate intake.
Number of subjects: 40
Study 19083486 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 40
Study 16545010 — intervention group
Group type: EXPERIMENTAL
Intervention: Enfuvirtide (ENF) + optimized background (OB) therapy
Number of subjects: 2
Study 16545010 — intervention group
Group type: COMPARATOR
Intervention: Optimized background (OB) therapy
Number of subjects: 2
Study 12956656 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste A
Number of subjects: 15
Study 12956656 — intervention group
Group type: COMPARATOR
Intervention: Toothpaste B
Number of subjects: 15
Study 12956656 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice
Number of subjects: 15
Study 12956656 — intervention group
Group type: COMPARATOR
Intervention: Drinking water
Number of subjects: 15
Study 12956656 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice and Toothpaste A
Number of subjects: 15
Study 12956656 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice and Toothpaste B
Number of subjects: 15
Study 11369148 — intervention group
Group type: COMPARATOR
Intervention: EC model leaflet
Number of subjects: 20
Study 11369148 — intervention group
Group type: EXPERIMENTAL
Intervention: Mark II leaflet
Number of subjects: 20
Study 9407172 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical melatonin (0.6 mg/cm2) applied 15 min before UV irradiation
Number of subjects: 20
Study 9407172 — intervention group
Group type: COMPARATOR
Intervention: Topical melatonin (0.6 mg/cm2) applied 1, 30, or 240 min after UV irradiation
Number of subjects: 20
Study 8269792 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 16
Study 3730239 — intervention group
Group type: EXPERIMENTAL
Intervention: Cricoid pressure using the cricoid yoke device
Number of subjects: 0
Study 3730239 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard practice without the cricoid yoke)
Number of subjects: 0
Study 29128440 — intervention group
Group type: EXPERIMENTAL
Intervention: McCall culdoplasty followed by standard cuff closure
Number of subjects: 50
Study 29128440 — intervention group
Group type: COMPARATOR
Intervention: Standard cuff closure
Number of subjects: 50
Study 27565224 — intervention group
Group type: EXPERIMENTAL
Intervention: OPC‐1085EL (n=118)
Number of subjects: 430
Study 27565224 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost (n=119)
Number of subjects: 430
Study 27565224 — intervention group
Group type: EXPERIMENTAL
Intervention: OPC‐1085EL (n=78)
Number of subjects: 430
Study 27565224 — intervention group
Group type: COMPARATOR
Intervention: Carteolol (n=78)
Number of subjects: 430
Study 27565224 — intervention group
Group type: EXPERIMENTAL
Intervention: Carteolol/latanoprost concomitant therapy (n=37)
Number of subjects: 430
Study 24764186 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine (TAPB)
Number of subjects: 83
Study 24764186 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (placebo block)
Number of subjects: 83
Study 23224706 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month outpatient exercise-based cardiac rehabilitation programme (group T)
Number of subjects: 46
Study 23224706 — intervention group
Group type: COMPARATOR
Intervention: Generic instructions for maintaining physical activity and correct lifestyle (group C)
Number of subjects: 46
Study 21645443 — intervention group
Group type: EXPERIMENTAL
Intervention: PRFA+PEI therapy group
Number of subjects: 75
Study 21645443 — intervention group
Group type: COMPARATOR
Intervention: PRFA control group
Number of subjects: 75
Study 18422519 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg sublingually
Number of subjects: 276
Study 18422519 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 0.05 mg intravenously
Number of subjects: 276
Study 18422519 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 0.1 mg intravenously
Number of subjects: 276
Study 18422519 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 276
Study 16598319 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (600 mg/day) for one month
Number of subjects: 99
Study 16598319 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil (600 mg twice daily) for one month
Number of subjects: 99
Study 16598319 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (600 mg/day) and Gemfibrozil (600 mg twice daily) combined for one month
Number of subjects: 99
Study 12902212 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (2-8 mg per day; mean dose=4.15±0.4 mg per day)
Number of subjects: 20
Study 12902212 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 20
Study 10768903 — intervention group
Group type: EXPERIMENTAL
Intervention: Three dimensional echocardiography
Number of subjects: 30
Study 10768903 — intervention group
Group type: COMPARATOR
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 30
Study 9151591 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate transmucosal implants with guided tissue regeneration
Number of subjects: 41